Pfizer, Covaxin, and SII developed vaccine are the three covid-19 vaccines which are going to be the part of India’s massive vaccination program that is yet to start. Government is about to launch a new app for the smooth running of the process. Here’s the full details.
India’s Take On Covid-19 Vaccine Program
This will be a huge vaccination program all over the world so it’s obvious to encounter challenges like storage facility for vaccine, ensuring vaccination for all, etc. But, India has past experience of conducting such programs on the huge scale.
Government has already indulged in the planning for the facilitate of vaccination to 30 crore Indians. To ensure that government does not fail to reach everyone from the priority groups, a new app called Co-Win has been launched.
It is the upgraded version of eVIN and users can download the app for free. However, they have to register for using the app which will provide the necessary information regarding the vaccination.
Know About The 5 Stages of Co-Win
- Administrator module for those conducting vaccination
- Registration for the users so that they can get vaccination
- Beneficiary acknowledgement to get confirmation and a QR-based certificate of vaccination
- Vaccination module that will keep the vaccination status and verify the details of registered users
- Report stage will have complete information of the sessions such as number of people get vaccinated, drop out users, and number of sessions been conducted, etc…
Apart from these modules, Co-Win will also give information regarding the cold-storage facilities of the vaccines. It would be real-time data and send directly to the main server of vaccination conducting agencies.
All the data will help performing the vaccine distribution in a seamless manner. It is also said to be helpful for users as it will keep them updated about the vaccination schedule and help them get the vaccine on time.
CO-Win is going to be a big help for both Indians and the government. As for now, the 3 vaccine at the doorsteps of India are only applicable for the emergency use where indigenously developed covaxin is under trials.